Found 25 clinical trials
NN2211-4232 LIRA-PRIME: Efficacy in controlling glycaemia with Victoza (liraglutide) as add-on to metformin vs. OAD's as add-on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes inadequately controlled with metformin monotherapy and treated in a primary care setting.
NN2211-4232 LIRA-PRIME: Efficacy in controlling glycaemia with Victoza (liraglutide) as add-on to metformin vs. OAD's as add-on to metformin after up to 104 weeks of treatment in subjects with type 2
- 495 views
- 25 Mar, 2021
- 1 location
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO)
, the most recent and most potent GLP1 agonist (superiority demonstrated compared to exenatide LP and dulaglutide) and administered as a weekly subcutaneous injection (in contrast to liraglutide
- 0 views
- 04 Oct, 2022
- 1 location
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
The purpose of this study is to assess the safety and efficacy of glucagon-like peptide-1 (GLP-1) analogue liraglutide in the treatment of acute minor stroke (National Institute of Health stroke
- 0 views
- 17 Feb, 2021
- 1 location
Liraglutide Effect in Atrial Fibrillation (LEAF)
amount of EAT, this study will use a medication called Liraglutide. This medication is known to work on fat deposits and produce weight loss. The investigator is conducting this study to find out if
- 29 views
- 14 May, 2022
- 1 location
Liraglutide Effects on Epicardial Fat Inflammatory Genes
serves as target for medications targeting the fat. Glucagon-like peptide-1 agonists (GLP-1A) are anti-diabetic medications with recently suggested cardio-protective properties. Liraglutide, a GLP-1A
- 7 views
- 12 Feb, 2022
- 1 location
Efficacy of Liraglutide Therapy in Patients With IPAA
randomized to liraglutide or placebo in a prospective cross over study.
- 0 views
- 14 Apr, 2022
- 1 location
Effects of LIraglutide on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging (LICAS-MR)
processes. It has also been demonstrated in a diabetic rat model that the administration of Liraglutide, a GLP-1 agonist, leads to normalization of myocardial steatosis associated with beneficial cardiac
- 0 views
- 07 Apr, 2022
- 1 location
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes (Liragest)
' liraglutide treatment could decrease the risk of T2D in obese women who have had gestational diabetes. The women are randomized either to liraglutide (Victoza ® 1.8 mg) or placebo group, once daily. Same
- 1 views
- 23 May, 2022
- 1 location
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
The aim of the trail is investigate the effect of liraglutide 1.8mg as add-on to insulin for 6 months on carotid intima media thickness and cardiovascular risk factors in subjects with type 1
- 0 views
- 04 Oct, 2022
The Effect of Different Diets on Arterial Stiffness in Obese Patients on Liraglutide
In patients initiating Liraglutide for weight management, the objective is to compare the effect of Med diet, high protein/low carbohydrate (HP/LC) diet and low fat (LF) control diet on CV
- 0 views
- 04 Oct, 2022
- 1 location